We invite you to join us at the Children with Diabetes Friends for Life Conference in Orlando for these presentations of note and booth activities, July 16-19, 2019.

Tandem announced its sponsorship of Project 50-in-50, a mountaineering challenge by two climbers with type 1 diabetes—Michael Shelver and Patrick Mertes. To achieve their goal, Shelver and Mertes will need to summit the highest peaks in each of the 50 United States in 50 days or less. Only two individuals have accomplished this before, none with type 1 diabetes.

Today we announced announced our sponsorship of Connected in Motion’s 2019 program calendar, featuring social and educational programing that builds community among people with type 1 diabetes. The funding will go to support Slipstream Retreats, adventure programs, and special projects in Ontario, British Columbia, the Yukon, and Alberta, Canada, including additional support for the Ontario Slipstream Retreat, hosted in partnership with Beyond Type 1.

Every day, Tandem pump users are doing their part to reduce, reuse, and recycle. As the only rechargeable insulin pumps on the market, Tandem insulin pumps have kept an estimated 4 million disposable batteries out of landfills since becoming available in 2012. We’re proud to do our small part to help reduce the number of disposable batteries going into our landfills.

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced its sponsorship of Beyond Type 1’s “Beyond Type Run,” an official charity partner of the 2019 TCS New York City Marathon. All Beyond Type Run team members have option to use t:slim X2 insulin pump for training and event.

Today we announced our sponsorship of BlueLoop, a care coordination resource for children with type 1 diabetes. BlueLoop, powered by the non-profit MyCareConnect Foundation, is a tool to help improve a family's ability to manage a child’s diabetes when the child is at school or away from home.

Today we announced our sponsorship of the Beyond Type 1 Snail Mail Club. Percy, the official Snail Mail mascot, will begin using the t:slim X2™ insulin pump as part of the new partnership!

On February 14, 2019, we announced that the t:slim X2™ insulin pump is the first to receive approval in a new device category called alternate controller enabled infusion (ACE) pumps. Here we break down what this REALLY means for our customers and the wider diabetes community.

We’re grateful to our distribution partners around the world helping us bring the t:slim X2™ insulin pump to you!

We've created a series of short instructional videos to highlight some of the features of the t:slim X2 insulin pump. Check out the first videos in this series!

We're proud to announce we have been named a top workplace in San Diego by The San Diego Union-Tribune and awarded a “Future Forward” 2018 Top Workplaces honor!

We’re here to answer some questions about the recent FDA approval of the t:slim X2 Insulin Pump with Basal-IQ™ Technology. Please note these answers are intended for our customers in the United States.

The FDA-Approved t:slim X2 Insulin Pump with Basal-IQ Technology and Dexcom G6® CGM System integration has arrived.

Attention, t:slim X2™ and t:slim G4™ Pump users! If you’re enjoying the CGM integration on your pump, please be sure to specifically request the CGM sensors compatible with your device next time you order supplies from Dexcom. If they don’t know you use an integrated Tandem device, you may automatically receive their new G6 system with your next order.

Full manufacturing operations have begun at our new facility in San Diego! The 50,000-square-foot Barnes Canyon facility doubles our previous manufacturing capacity for both insulin pumps and cartridges in support of the our growing operations.

It’s the perfect time to explore new technology and to take advantage of the remaining funds in your Flexible Spending Account or Health Savings Account. These funds often don’t carry over to the next year, so make sure not to end the year with unclaimed health benefits – year end will be here sooner than you think!

We believe competition is important to push companies to constantly innovate for people with diabetes and provide the highest level of quality and service at a reasonable price. For that reason, we are disappointed by this week’s news that Animas is exiting the U.S. pump market and have designated Medtronic as a preferred partner to transition customers.

Upon FDA approval of Dexcom G5 Mobile CGM compatibility, thousands of existing t:slim X2 Insulin Pump users were able to add CGM integration to their pump from home using their personal computer, without waiting for their insurance to cover a new device. Just four weeks after launch of the software update, one-third of users have already updated their pumps via personal computer. Of the t:slim X2 Pump users who have taken advantage of the software update, more than 85% indicated they were satisfied or extremely satisfied with the update process.

Up until recently, insulin pumps didn’t change that much - they did basal, they did bolus, and that was about it, so the typical 4-year insurance company reimbursement cycle wasn’t really a big deal. But the pace of innovation in diabetes technology has picked up rapidly. What if you could choose a pump today that could be updated with new features as they become approved and available?

In case you have to relocate, we’ve included a packing list of important items you may need if you are being evacuated and have limited time to pack. In the event that you or someone you know have difficulty accessing supplies for a Tandem pump, our Customer Technical Support team is available 24/7 at 1-877-801-6901 and can help you coordinate with local resources for assistance in your area.